Using an integrated systems-level approach that includes transcriptome, proteome, translatome, and metabolome profiling, we show that in a subset of cancer cells, GCN2 prevents excessive ribosome biogenesis and protein synthesis under conditions of optimal nutrient availability. The gene discussed is EIF2AK4; the disease is cancer.